Reports & Presentations
Subsidiary Financials 2019 -20
- Glenmark Life Sciences Limited
- Glenmark Distribuidora de Medicamentos e Produtos
- Glenmark Dominicana SRL
- Glenmark Farmaceutica Ltda
- Glenmark Holding S.A
- Glenmark Pharma Coloumbia
- Glenmark Pharmaceuticals Australia (Pty) Ltd
- Glenmark Pharmaceuticals Egypt, S.A.E
- Glenmark Pharmaceuticals FZE
- Glenmark Pharmaceuticals (Malaysia) Sdn Bhd
- Glenmark Pharmaceuticals B.V.
- Glenmark Pharmaceuticals Canada Inc.
- Glenmark Pharmaceuticals Distribution S.R.O
- Glenmark Pharmaceuticals Ecuador S.A
- Glenmark Pharmaceuticals Europe Limited
- Glenmark Pharmaceuticals Europe R&D Limited
- Glenmark Pharmaceuticals Inc., USA
- Glenmark Pharmaceuticals Kenya Ltd
- Glenmark Pharmaceuticals Mexico S.A. DE C.V.
- Glenmark Pharmaceuticals Nordic AB
- Glenmark Pharmaceuticals Peru SAC
- Glenmark Pharmaceuticals S.R.L
- Glenmark Pharmaceuticals S.R.O Prague
- Glenmark Pharmaceuticals Singapore
- Glenmark Pharmaceuticals SK, SRO Bratislava
- Glenmark Pharmaceuticals south Africa
- Glenmark Pharmaceuticals SP z.o.o.
- Glenmark Pharmaceuticals Thailand
- Glenmark Pharmaceuticals Venezuela, C.A
- Glenmark Philippines, Inc
- Glenmark South Africa (pty) Ltd
- Glenmark Ukraine
- Glenmark Uruguay S.A.
- Ichnos Sciences BSA
- Viso Farmaceutica S.L.U
